Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.950
-0.110 (-2.71%)
At close: Jan 29, 2026, 4:00 PM EST
3.950
0.00 (0.00%)
After-hours: Jan 29, 2026, 4:00 PM EST
Exagen Market Cap
Exagen has a market cap or net worth of $87.93 million as of January 29, 2026. Its market cap has increased by 59.80% in one year.
Market Cap
87.93M
Enterprise Value
80.22M
1-Year Change
59.80%
Ranking
Category
Stock Price
$3.95
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $87.93M, an increase of 39.34%. That is a compound annual growth rate of 5.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 92.01M | -33.22% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myriad Genetics | 541.57M |
| Burning Rock Biotech | 381.03M |
| Prenetics Global | 308.80M |
| Insight Molecular Diagnostics | 188.33M |
| MDxHealth | 183.64M |
| FONAR | 122.05M |
| Biodesix | 80.27M |
| Precipio | 43.80M |